Left main and multivessel disease

View a selection of hot lines from PCR e-Course 2020 on the topic of left main & multivessel disease:

• One-year clinical outcomes of complex PCI treated with use of Ultimaster stent
• Impact of residual SYNTAX score on all-cause death at 10 yrs in the SYNTAX trial

Watch this session if you want to review steps for PCI in complex left main bifurcation lesions, to advance your knowledge on IVUS-guided PCI in left main disease and to learn about a purpose-built new stent platform for large vessels and left main.

Watch this session if you want to understand why the left main PCI approach and techniques are unique to the anatomy, to understand the EBC consensus and other evidence on left main PCI and to review a left main PCI real world case.

Speakers: Goran Stankovic, Francesco...

The presented results appear to further strengthen the notion that operator’s experience may be an important effect modifier in LM PCI.

This study compares outcomes of patients enrolled in the National Cardiogenic Shock Initiative (NCSI) registry treated using a strategy of MV-PCI vs CV-PCI and examines outcomes in patients treated with early MCS.

View the discussion of this case between Salvatore Brugaletta, Kalaivani Mahadevan and Thomas Johnson.

This 10-year follow-up of the randomised PRECOMBAT trial adds to the already published long-term randomised comparisons of PCI vs. CABG for LM disease, including the data from SYNTAX (10 years), EXCEL (5 years) and NOBLE (5 years) trials.

The objective of this analysis was to investigate the potential benefits of FKI in bifurcations treated with new generation ultrathin stents using a 1- or 2-stent technique.

A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak has been declared a Public Health Emergency of International Concern by the WHO since January 2020. The rapid, exponential, increase in confirmed cases makes prevention and control of coronavirus disease (COVID-19) extremely critical. Although clinical manifestations of...

A good systematic review and meta-analysis can be a great help in sorting out apparently conflicting studies. But the results of meta-analyses themselves can vary. We need more people to be able to read them critically, and to see why meta-analyses become conflicting results themselves.